ANASTROZOLE Drug Patent Profile
✉ Email this page to a colleague
When do Anastrozole patents expire, and when can generic versions of Anastrozole launch?
Anastrozole is a drug marketed by Accord Hlthcare, Apotex Inc, Beijing Yiling, Chartwell Molecular, Chartwell Rx, Cipla, Eugia Pharma, Fresenius Kabi Usa, Hikma, Impax Labs Inc, Kenton, Natco Pharma Ltd, Norvium Bioscience, Sandoz, Sun Pharm Inds Ltd, Synthon Pharms, Teva Pharms, Watson Labs Teva, and Zydus Pharms Usa Inc. and is included in nineteen NDAs.
The generic ingredient in ANASTROZOLE is anastrozole. There are twenty-four drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the anastrozole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Anastrozole
A generic version of ANASTROZOLE was approved as anastrozole by ACCORD HLTHCARE on June 28th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ANASTROZOLE?
- What are the global sales for ANASTROZOLE?
- What is Average Wholesale Price for ANASTROZOLE?
Summary for ANASTROZOLE
| US Patents: | 0 |
| Applicants: | 19 |
| NDAs: | 19 |
| Finished Product Suppliers / Packagers: | 23 |
| Raw Ingredient (Bulk) Api Vendors: | 119 |
| Clinical Trials: | 316 |
| Drug Prices: | Drug price information for ANASTROZOLE |
| Drug Sales Revenues: | Drug sales revenues for ANASTROZOLE |
| DailyMed Link: | ANASTROZOLE at DailyMed |
See drug prices for ANASTROZOLE
Recent Clinical Trials for ANASTROZOLE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Breast Cancer Research Foundation | Phase 2 |
| University of Wisconsin, Madison | Phase 2 |
| GOG Foundation | Phase 3 |
Pharmacology for ANASTROZOLE
| Drug Class | Aromatase Inhibitor |
| Mechanism of Action | Aromatase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for ANASTROZOLE
US Patents and Regulatory Information for ANASTROZOLE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord Hlthcare | ANASTROZOLE | anastrozole | TABLET;ORAL | 090568-001 | Jun 28, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs Teva | ANASTROZOLE | anastrozole | TABLET;ORAL | 078984-001 | Jun 28, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Eugia Pharma | ANASTROZOLE | anastrozole | TABLET;ORAL | 212434-001 | Jul 24, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Molecular | ANASTROZOLE | anastrozole | TABLET;ORAL | 091331-001 | Jan 5, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Natco Pharma Ltd | ANASTROZOLE | anastrozole | TABLET;ORAL | 079220-001 | Jun 28, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | ANASTROZOLE | anastrozole | TABLET;ORAL | 090088-001 | Jun 28, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Pharms Usa Inc | ANASTROZOLE | anastrozole | TABLET;ORAL | 078921-001 | Jun 28, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
